| Name | Title | Contact Details |
|---|
Hemarus is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns` programs are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients. Terns` investors include OrbiMed, Vivo Capital, Lilly Asia Ventures, and Decheng Capital.
Better data. Better insights. Better outcomes for behavioral health.
The Investor Relations website contains information about Cingulate Incs business for stockholders, potential investors, and financial analysts.
Shasun USA Inc is a Piscataway, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.